Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

A MUM who lost a staggering nine stone on a weight-loss jab says her hair started falling out in clumps, until she found an ...

Harvard T.H. Chan School of Public Health suggests combining GLP-1 weight-loss medication with tailored nutrition and ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

Pharmacies have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable 🚨 ...

India's weight-loss game is getting serious! The country's anti-obesity market is now worth ₹628 crore, and it's climbing ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...